New Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis released Dr. Kamal Kant Kohli7 May 2022 10:45 AM ISTThe American Thoracic Society-in collaboration with the European Respiratory Society, Japanese Respiratory Society and Asociacion Latinoamericana de...
Nintedanib found effective for drug resistant gastrointestinal stromal tumors Dr. Kamal Kant Kohli15 April 2022 7:30 PM ISTNintedanib could be used in the treatment of drug-resistant gastrointestinal stromal tumors (GISTs), finds a research led by Prof. LIU Qingsong and...
What was the optimal dose of pirfenidone in large studies on idiopathic pulmonary fibrosis? Dr. Kamal Kant Kohli9 Dec 2021 12:00 PM ISTIdiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal lung disease that is characterized by the irreversible loss of lung function....
Tobacco smoking tied to risk of pulmonary fibrosis: Study Medha Baranwal22 Sept 2021 9:45 AM ISTGreece: Active and maternal smoking are independently related to the risk of idiopathic pulmonary fibrosis (IPF) and work synergistically, a recent...
JB Chemicals and Pharmaceuticals launches Nintedanib for treatment in Idiopathic Pulmonary Fibrosis (IPF) Meghna A Singhania26 Jun 2021 11:06 AM ISTMumbai: J.B. Chemicals & Pharmaceuticals Ltd. today announced the launch of 'Nintabid' Capsules containing Nintedanib 100mg and 150mg, an oral...
New Ultrasound technique may precisely assess pulmonary fibrosis and pulmonary edema Medical Dialogues Bureau26 Oct 2020 8:53 AM ISTResearchers from North Carolina State University and the University of North Carolina have developed a technique that uses ultrasound to provide...
Glenmark launches pulmonary fibrosis drug NINDANIB in India Ruchika Sharma14 Oct 2020 1:00 PM ISTNintedanib is approved by the Indian drug regulator for the treatment of Idiopathic (unknown cause) Pulmonary Fibrosis (IPF).
